Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
inTEST Corp (INTT)
AMEXInformation TechnologySemiconductorsSnapshot 2026-11-04
$12.30-12.14%
Close 2026-11-05 · 1-day change
AMEXInformation TechnologySemiconductorsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.66 → 0.70 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for INTT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain gross margin at approximately 45% | Gross margin should stay near 45%. | Broken | Gross margin falls below 43% in 2026 | Gross margin: 40.49% FY2026-Q2; GAAP. Published target: ~45%. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 202640.489338 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “Reflecting its recently revised full-year 2026 financial guidance, the Company expects revenue of $135.0 million to $140.0 million; gross margin of approximately 43%; operating expenses of $55.0 million to $57.0 million; amortization expense of $2.6 million; interest expense of $0.3 million; an effective tax rate of approximately 18%; and capital expenditures estimated at approximately 1% to 2% of revenue.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 6, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
INTT is a higher-risk growth business, not yet a proven steady compounder. Its long-term thesis is intact, supported by recent earnings beats and rising revenue guidance, but the evidence is mixed because margins have weakened.
The valuation signal describes INTT as cheap versus peers, with a small expectations gap, and marks pricing as justified. Valuation has fallen recently, but the evidence does not show that the market is already assuming a large improvement in results.
Near term, revenue growth has been supported by stronger demand and backlog, and management raised its 2026 revenue guidance. Gross margin fell to 40.5% in 2026-Q2, below the stated goal, while operating expenses remain within guidance; ERP issues and mix shifts are cited as pressures.
The multi-year thesis depends on revenue growth continuing while margins stabilize and costs stay controlled. A reversal and guidance cut would damage management credibility, while easing rates or steadier results from major technology peers could support the sector backdrop.
Over the next 1 to 3 years, INTT has a credible growth case but carries high risk, with margin recovery and reliable execution as the main tests. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Control operating expenses at $55M-$57M for 2026 | Operating expenses control is a challenge but progress is ongoing. | Intact | Operating expenses exceed $57 million in 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “Reflecting its recently revised full-year 2026 financial guidance, the Company expects revenue of $135.0 million to $140.0 million; gross margin of approximately 43%; operating expenses of $55.0 million to $57.0 million; amortization expense of $2.6 million; interest expense of $0.3 million; an effective tax rate of approximately 18%; and capital expenditures estimated at approximately 1% to 2% of revenue.” Delivery assessment Nov 4, 2026 |
Increase revenue to $130M-$135M for 2026 | A primary condition in inTEST Corp's published investment case. The stated target is >= $130 million. | Intact | Full-year revenue falls below $130 million in 2026 | Revenue: $35.313M FY2026-Q2; GAAP. Published target: >= $130 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 202635,313,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Third Quarter 2026 and Raised Full Year 2026 Outlook Mr. Rogoff concluded, “We are reiterating the full-year 2026 guidance we updated on July 31, which raised our revenue outlook to approximately 21% growth at the midpoint over 2025's $113.8 million, and modestly reduced our gross margin expectation.” “This outlook reflects diversified demand supported by our backlog, along with improving order flow and product mix in the second half.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.63 → $0.70 · observed estimates
$0.14B → $0.15B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.63 | $143,212,670 | 3 / 3 |
| 2026-07-25 | $0.63 | $143,212,667 | 2 / 2 |
| 2026-07-26 | $0.63 | $143,212,670 | 3 / 3 |
| 2026-07-27 | $0.63 | $143,212,667 | 2 / 2 |
| 2026-07-28 | $0.63 | $143,212,667 | 2 / 2 |
| 2026-07-29 | $0.63 | $143,212,670 | 3 / 3 |
| 2026-07-30 | $0.63 | $143,212,670 | 3 / 3 |
| 2026-07-31 | $0.63 | $143,212,670 | 3 / 3 |
| 2026-08-01 | $0.63 | $143,212,667 | 2 / 2 |
| 2026-08-02 | $0.63 | $143,212,670 | 3 / 3 |
| 2026-08-03 | $0.68 | $145,311,000 | 2 / 3 |
| 2026-08-04 | $0.68 | $145,311,000 | 2 / 3 |
| 2026-08-05 | $0.73 | $147,904,000 | 3 / 3 |
| 2026-08-06 | $0.73 | $147,904,000 | 3 / 3 |
| 2026-08-07 | $0.73 | $147,904,000 | 2 / 2 |
| 2026-08-08 | $0.73 | $147,904,000 | 3 / 3 |
| 2026-08-09 | $0.73 | $147,904,000 | 3 / 3 |
| 2026-08-10 | $0.73 | $147,904,000 | 3 / 3 |
| 2026-08-12 | $0.73 | $147,904,000 | 2 / 2 |
| 2026-08-13 | $0.73 | $147,904,000 | 2 / 2 |
| 2026-08-14 | $0.73 | $147,904,000 | 2 / 2 |
| 2026-08-15 | $0.73 | $147,904,000 | 2 / 2 |
| 2026-08-16 | $0.73 | $147,904,000 | 2 / 2 |
| 2026-08-17 | $0.73 | $147,904,000 | 2 / 2 |
| 2026-08-18 | $0.73 | $147,904,000 | 2 / 2 |
| 2026-08-19 | $0.73 | $147,904,000 | 2 / 2 |
| 2026-08-20 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-21 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-22 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-23 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-24 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-25 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-26 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-27 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-28 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-29 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-30 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-08-31 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-01 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-02 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-03 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-04 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-05 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-06 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-07 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-08 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-09 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-10 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-11 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-12 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-13 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-14 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-15 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-16 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-17 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-18 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-19 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-20 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-21 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-22 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-23 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-24 | $0.66 | $148,092,000 | 2 / 2 |
| 2026-09-25 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-09-26 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-09-27 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-09-28 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-09-29 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-09-30 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-10-01 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-10-02 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-10-03 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-10-04 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-10-05 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-10-06 | $0.66 | $148,100,333 | 2 / 2 |
| 2026-10-07 | $0.69 | $148,748,333 | 2 / 2 |
| 2026-10-08 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-09 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-10 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-11 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-12 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-13 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-14 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-15 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-16 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-17 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-18 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-19 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-20 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-21 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-22 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-23 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-24 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-25 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-26 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-27 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-28 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-29 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-30 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-10-31 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-11-01 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-11-02 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-11-03 | $0.70 | $149,114,333 | 2 / 2 |
| 2026-11-04 | $0.70 | $149,114,333 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.